Sodium bicarbonate is a white, crystalline powder that is commonly used as a pH buffering agent, an electrolyte replenisher, systemic alkalizer and in topical cleansing solutions.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Atazanavir | Sodium bicarbonate can cause a decrease in the absorption of Atazanavir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Bosutinib | Sodium bicarbonate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cefditoren | The serum concentration of Cefditoren can be decreased when it is combined with Sodium bicarbonate. |
| Dabigatran etexilate | Sodium bicarbonate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dabrafenib | Sodium bicarbonate can cause a decrease in the absorption of Dabrafenib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dasatinib | Sodium bicarbonate can cause a decrease in the absorption of Dasatinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Delavirdine | Sodium bicarbonate can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Erlotinib | Sodium bicarbonate can cause a decrease in the absorption of Erlotinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gefitinib | Sodium bicarbonate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Itraconazole | Sodium bicarbonate can cause a decrease in the absorption of Itraconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ledipasvir | Sodium bicarbonate can cause a decrease in the absorption of Ledipasvir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Methylphenidate | Sodium bicarbonate can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects. |
| Pazopanib | Sodium bicarbonate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Riociguat | Sodium bicarbonate can cause a decrease in the absorption of Riociguat resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Levothyroxine | Sodium bicarbonate can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Acetazolamide | The risk or severity of adverse effects can be increased when Acetazolamide is combined with Sodium bicarbonate. |
| Flecainide | Sodium bicarbonate may decrease the arrhythmogenic activities of Flecainide. |
| Tolevamer | The risk or severity of adverse effects can be increased when Tolevamer is combined with Sodium bicarbonate. |
| Lithium citrate | Sodium bicarbonate may increase the excretion rate of Lithium citrate which could result in a lower serum level and potentially a reduction in efficacy. |
| Lithium carbonate | Sodium bicarbonate may increase the excretion rate of Lithium carbonate which could result in a lower serum level and potentially a reduction in efficacy. |
| Lithium hydroxide | Sodium bicarbonate may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy. |
| Bisacodyl | The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Sodium bicarbonate. |
| Captopril | Sodium bicarbonate can cause a decrease in the absorption of Captopril resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cefpodoxime | The serum concentration of Cefpodoxime can be decreased when it is combined with Sodium bicarbonate. |
| Cefuroxime | The serum concentration of Cefuroxime can be decreased when it is combined with Sodium bicarbonate. |
| Chloroquine | Sodium bicarbonate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Elvitegravir | Sodium bicarbonate can cause a decrease in the absorption of Elvitegravir resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Hyoscyamine | Sodium bicarbonate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rifampin | Sodium bicarbonate can cause a decrease in the absorption of Rifampicin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mecamylamine | Sodium bicarbonate may decrease the excretion rate of Mecamylamine which could result in a higher serum level. |
| Memantine | Sodium bicarbonate may decrease the excretion rate of Memantine which could result in a higher serum level. |
| Quinidine | Sodium bicarbonate may decrease the excretion rate of Quinidine which could result in a higher serum level. |
| Sulpiride | The therapeutic efficacy of Sulpiride can be increased when used in combination with Sodium bicarbonate. |
| Allopurinol | The therapeutic efficacy of Allopurinol can be decreased when used in combination with Sodium bicarbonate. |
| Raltegravir | The serum concentration of Raltegravir can be decreased when it is combined with Sodium bicarbonate. |
| Mesalazine | Sodium bicarbonate can cause a decrease in the absorption of Mesalazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mycophenolate mofetil | Sodium bicarbonate can cause a decrease in the absorption of Mycophenolate mofetil resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mycophenolic acid | Sodium bicarbonate can cause a decrease in the absorption of Mycophenolic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cysteamine | The bioavailability of Cysteamine can be decreased when combined with Sodium bicarbonate. |
| Ketoconazole | Sodium bicarbonate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Thiethylperazine | Sodium bicarbonate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Promazine | Sodium bicarbonate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Prochlorperazine | Sodium bicarbonate can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Chlorpromazine | Sodium bicarbonate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Triflupromazine | Sodium bicarbonate can cause a decrease in the absorption of Triflupromazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Fluphenazine | Sodium bicarbonate can cause a decrease in the absorption of Fluphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Thioridazine | Sodium bicarbonate can cause a decrease in the absorption of Thioridazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Moricizine | Sodium bicarbonate can cause a decrease in the absorption of Moricizine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Trifluoperazine | Sodium bicarbonate can cause a decrease in the absorption of Trifluoperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Perphenazine | Sodium bicarbonate can cause a decrease in the absorption of Perphenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Mesoridazine | Sodium bicarbonate can cause a decrease in the absorption of Mesoridazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Acetophenazine | Sodium bicarbonate can cause a decrease in the absorption of Acetophenazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Promethazine | Sodium bicarbonate can cause a decrease in the absorption of Promethazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Alimemazine | Sodium bicarbonate can cause a decrease in the absorption of Alimemazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Methotrimeprazine | Sodium bicarbonate can cause a decrease in the absorption of Methotrimeprazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Periciazine | Sodium bicarbonate can cause a decrease in the absorption of Periciazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Acepromazine | Sodium bicarbonate can cause a decrease in the absorption of Acepromazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Aceprometazine | Sodium bicarbonate can cause a decrease in the absorption of Aceprometazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pipotiazine | Sodium bicarbonate can cause a decrease in the absorption of Pipotiazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Thioproperazine | Sodium bicarbonate can cause a decrease in the absorption of Thioproperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| BL-1020 | Sodium bicarbonate can cause a decrease in the absorption of BL-1020 resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cyamemazine | Sodium bicarbonate can cause a decrease in the absorption of Cyamemazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Methylene blue | Sodium bicarbonate can cause a decrease in the absorption of Methylene blue resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Propiopromazine | Sodium bicarbonate can cause a decrease in the absorption of Propiopromazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Perazine | Sodium bicarbonate can cause a decrease in the absorption of Perazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Butaperazine | Sodium bicarbonate can cause a decrease in the absorption of Butaperazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Chlorproethazine | Sodium bicarbonate can cause a decrease in the absorption of Chlorproethazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Thiazinam | Sodium bicarbonate can cause a decrease in the absorption of Thiazinam resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Dixyrazine | Sodium bicarbonate can cause a decrease in the absorption of Dixyrazine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Perphenazine enanthate | Sodium bicarbonate can cause a decrease in the absorption of Perphenazine enanthate resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Doxycycline | Sodium bicarbonate can cause a decrease in the absorption of Doxycycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lymecycline | Sodium bicarbonate can cause a decrease in the absorption of Lymecycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Clomocycline | Sodium bicarbonate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Oxytetracycline | Sodium bicarbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Demeclocycline | Sodium bicarbonate can cause a decrease in the absorption of Demeclocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Tetracycline | Sodium bicarbonate can cause a decrease in the absorption of Tetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Metacycline | Sodium bicarbonate can cause a decrease in the absorption of Metacycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Minocycline | Sodium bicarbonate can cause a decrease in the absorption of Minocycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sarecycline | Sodium bicarbonate can cause a decrease in the absorption of Sarecycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Omadacycline | Sodium bicarbonate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Penimepicycline | Sodium bicarbonate can cause a decrease in the absorption of Penimepicycline resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Triethylenetetramine | Sodium bicarbonate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rosuvastatin | Sodium bicarbonate can cause a decrease in the absorption of Rosuvastatin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pamidronic acid | The serum concentration of Pamidronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Zoledronic acid | The serum concentration of Zoledronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Alendronic acid | The serum concentration of Alendronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Ibandronate | The serum concentration of Ibandronate can be decreased when it is combined with Sodium bicarbonate. |
| Clodronic acid | The serum concentration of Clodronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Risedronic acid | The serum concentration of Risedronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Etidronic acid | The serum concentration of Etidronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Tiludronic acid | The serum concentration of Tiludronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Incadronic acid | The serum concentration of Incadronic acid can be decreased when it is combined with Sodium bicarbonate. |
| Betamethasone | The bioavailability of Betamethasone can be decreased when combined with Sodium bicarbonate. |
| Fluticasone propionate | The bioavailability of Fluticasone propionate can be decreased when combined with Sodium bicarbonate. |
| Triamcinolone | The bioavailability of Triamcinolone can be decreased when combined with Sodium bicarbonate. |
| Prednisone | The bioavailability of Prednisone can be decreased when combined with Sodium bicarbonate. |
| Fludrocortisone | The bioavailability of Fludrocortisone can be decreased when combined with Sodium bicarbonate. |
| Hydrocortisone | The bioavailability of Hydrocortisone can be decreased when combined with Sodium bicarbonate. |
| Prednisolone | The bioavailability of Prednisolone can be decreased when combined with Sodium bicarbonate. |
| Methylprednisolone | The bioavailability of Methylprednisolone can be decreased when combined with Sodium bicarbonate. |